Judges Scientific - FY23 results marginally ahead; FY24 small upgrades, the model keeps performing

Judges Scientific is a group involved in the buy and build of scientific instrumentation businesses. Testament to the strength of its highly engineered offer and global diversified customer base, total revenue increased an impressive 20.2% to £136.1m (organic +15%), with adj. PBT +7.5% to £31.7m (FY2022: £28.3m), 3.1% ahead of our estimate of £30.5m. Fully diluted (FD) adjusted EPS increased a more muted 2.6% (impacted by anticipated tax headwinds) to 368.5p (basic adj EPS 374.5p), 3.4% ahead of

Judges Scientific+ (JDG, House Stock at 11,600p) - FY23A - solid organic order book

LIBERUM: Judges Scientific: FY23 in line, with an historic dividend

Judges Scientific - Small accretive bolt-on further evidences the model

Judges Scientific, the group focused on acquiring and developing companies in the scientific instrument sector, has announced that it has acquired Swiss based Luciol Instruments SA, a company that manufactures and sells instruments to measure optic fibre properties. The entire issued share capital has been acquired by Judges' subsidiary PE.Fiberoptics Ltd (Luciol deploying similar technology in different markets) for a maximum cash consideration of CHF2.5m (£2.3m), of which CHF2.0m is payable u

Judges Scientific+ (JDG, House Stock at 9,200p) - Small acquisition, Switzerland

LIBERUM: Judges Scientific: Strong finish to FY23E

Judges Scientific+ (JDG, House at 9,300p) - FY23F update - in line, good organic

Judges Scientific+ (JDG, House Stock at 8,900p) - HY; strong order book, FY23F unchanged

Judges Scientific - Interim results – Excellent H1 underpins FY2023 with upside potential to FY2024E

Judges Scientific is a group focused on acquiring and developing companies in the scientific instrument sector. Judges has delivered an excellent first half with order books reaching a new mid-year record of 22.4 weeks. H1 revenue increased by 32% (organic +16.5%) to £61.3m (H1-22: £46.4m) which helped yield an adjusted pre-tax profit of £12.8m (H1-22 £9.6m), a 33% YoY increase (organic: +12%), with EBITA margin climbing to 23.2% (H1-22: 21.8%). Adjusted fully diluted EPS increased 22% to 150.3p

LIBERUM: Judges Scientific: Strong H1, FY23E well underpinned

LIBERUM: Judges Scientific: A COO's insight to the success of Judges

Hybridan Small Cap Feast - 18 Jul 23

18th July 2023 @HybridanLLP Status of this Note and Disclaimer This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objecti

Judges Scientific - Strong first half, holding FY2023 estimates, but with upside risk

Judges Scientific is a group focused on acquiring and developing companies in the scientific instrument sector. The first half looks to have demonstrated a solid performance, with management ‘confident' of hitting full year market expectations given a strong order book and the business demonstrating resilience across all key global markets. We hold our FY2023 estimates which look for revenue of £129.9m, adjusted PBT of £30.7m (ca. +24% YoY) and basic adjusted EPS of 365.7p (+0.5% YoY).